bioRxivCell Biology
Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization
M. Berquez, Z. Chen, B. P. Festa, P. Krohn, S. A. Keller, S. Parolo, M. Korzinkin, A. Gaponova, E. Laczko, E. Domenici, O. Devuyst, A. Luciani
Abstract
Differentiation is critical for cell fate decisions, but the signals involved remain unclear. The kidney proximal tubule (PT) cells reabsorb disulphide-rich proteins through endocytosis, generating cystine via lysosomal proteolysis. Here we report that defective cystine mobilization from lysosomes through cystinosin (CTNS), which is mutated in cystinosis, diverts PT cells towards growth and proliferation, disrupting their functions. Mechanistically, cystine storage stimulates Ragulator-Rag GTPase-dependent recruitment of mechanistic target of rapamycin complex 1 (mTORC1) and its constitutive activation. Re-introduction of CTNS restores nutrient-dependent regulation of mTORC1 in knockout cells, whereas cell-permeant analogues of L-cystine, accumulating within lysosomes, render wild-type cells resistant to nutrient withdrawal. Therapeutic mTORC1 inhibition corrects lysosome and differentiation downstream of cystine storage, and phenotypes in a zebrafish model of cystinosis. Thus, cystine serves as a lysosomal signal that tailors mTORC1 and metabolism to direct epithelial cell fate decisions. These results identify mechanisms and therapeutic targets for dysregulated homeostasis in cystinosis.
- organism: zebrafish
- research focus: cell type annotation
- research focus: development & morphogenesis
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SGLT2 Inhibitors Rescue Lysosomal mTORC1 Hyperactivity and Proximal Tubulopathy in Preclinical Models of Cystinosis
Svenja Aline Keller, Patrick Krohn, … Olivier Devuyst·bioRxiv·Feb 3, 2026
- Use of human iPSCs and kidney organoids to develop a cysteamine/mTOR inhibition combination therapy to treat cystinosis
J. A. Hollywood, A. Przepiorski, … T. M. Holm·bioRxiv·Apr 1, 2019
- Novel Mechanism for Tubular Injury in Nephropathic Cystinosis
S. Sur, M. Kerwin, … M. M. Sarwal·bioRxiv·May 13, 2022
- Cystinosin is involved in Na+/H+ Exchanger 3 trafficking in the proximal tubular cells: new insights in the renal Fanconi syndrome in cystinosis
Veenita Khare, Jean‐Claude Farré, … Stéphanie Cherqui·bioRxiv·Feb 12, 2025
- DYNC1LI2 regulates localization of the chaperone-mediated autophagy-receptor LAMP2A and improves cellular homeostasis in cystinosis
F. Rahman, J. L. Johnson, … S. D. Catz·bioRxiv·Jun 9, 2020
- Rag GTPases Suppress Renal Cystic Disease by Inhibiting TFEB Independently of mTORC1
Flaviane de Fátima Silva, Alexander R. Boucher, … David A. Guertin·bioRxiv·Jul 24, 2025